Biosimilars Manufacturing and Sourcing Dynamics
Presented by the Education Commitee of DCAT    


      Official Media Partner


With healthcare reform in the forefront of the daily news, one of the largest opportunities for new entries is in the field of biosimilars/follow-on biologics. Many companies have announced a strategy to develop follow-on biologics, seemingly entering the generic side of biologics, as well as alliances between manufacturing and generic companies.

Learn more about this highly visible market on:

Wednesday, December 2, 2009
10:30 am - 4:00 pm
Hilton Hotel 
Parsippany, NJ 


Attend this unique DCAT program to learn more about biosimilars: 
    • Market overview and opportunities 
    • Development and manufacturing dynamics 
    • Regulatory approval 
    • Technologies for active ingredients and formulations 

Who should attend: 
    • Sourcing 
    • Sales & marketing 
    • Business development


Program fee includes lunch & refreshments:
    DCAT Members:    $229
    Non-members:      $459